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Conclusion Marginal or periosteal bone resection of the 
mandible was identified as the highest ORN risk factor in 
our IMRT cohort.
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Risikoprofil für Osteoradionekrosen des Kiefers 
in der IMRT-Ära
Zusammenfassung
Hintergrund Das Risiko für die Entwicklung einer Kie-
fernekrose nach Radiotherapie (Osteoradionekrose, ORN) 
korreliert bekanntlich mit dem Knochenvolumen, das einer 
Dosis von ~ > 60 Gy ausgesetzt wurde. Hypothese war, dass 
die Chirurgie bei kombinierten Therapien ebenfalls einen 
Risikofaktor darstellt.
Material und Methode Der Einfluss chirurgischer Interven-
tionen am Kiefer auf das Risiko einer ORN wurde in un-
serem lokal krankheitsfreien IMRT-Kollektiv retrospektiv 
analysiert.
Ergebnisse Zwischen Oktober 2002 und Oktober 2013 wur-
den 531/715 Patienten mit Mundhöhlenkarzinomen (OCC), 
Mesopharynxkarzinomen (MC) oder Speicheldrüsentumo-
ren mit Dosen > 60 Gy am Kieferknochen behandelt (mitt-
lere Beobachtungszeit 38 Monate; Spanne 7–143 Monate). 
Von 531 Patienten entwickelten 36 eine ORN (7 %; 1,5 % 
mit Grad 3–4). Die ORN-Rate nach definitiver IMRT bei 
MC (16/227) und nach postoperativer IMRT bei OCC ohne 
chirurgischen Eingriff am Kieferknochen (3/46) belief sich 
auf je 7 %, bei OCC-Patienten mit Operation am Kieferkno-
chen auf 29 % (15/60; p = 0,002). Das höchste ORN-Risiko 
fand sich dabei für marginale oder periosteale Knochenre-
Abstract
Background The risk for osteoradionecrosis (ORN) of the 
mandible is positively related to bone volume exposed to 
> ~ 60 Gy. We hypothesized that in combined treatment, sur-
gery may also be a risk factor.
Patients and methods The impact of mandibular surgery on 
ORN in locally disease-free IMRT cohorts was retrospec-
tively analyzed.
Results Between October 2002 and October 2013, 531 of 
715 patients with oral cavity cancer (OCC), mesopharyn-
geal cancer (MC), or salivary gland tumor were treated with 
the mandible bone exposed to ~ > 60 Gy (mean follow-up, 
38 months; 7–143 months). Of the 531 patients, 36 devel-
oped ORN (7 %; 1.5 % with grade 3–4). The ORN rate in 
definitive IMRT MC (16/227) and in postoperative IMRT 
OCC patients with no mandibular surgery (3/46) was 7 % 
each; in OCC patients with mandibular surgery the rate was 
29 % (15/60, p = 0.002). Marginal or periosteal bone resec-
tion was found to be a high risk factor (39 %, vs. 7 % fol-
lowed by segmental or no resection, p < 0.0001).
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sektionen (39 %, vs. 7 % nach segmentaler oder keiner Re-
sektion; p < 0,0001).
Schlussfolgerung Marginale oder periosteale Kieferkno-
chenresektionen gingen in unserer IMRT-Kohorte mit dem 
höchsten Risiko für die Entwicklung einer ORN einher.
Schlüsselwörter Osteoradionekrose, ORN · 
Risikofaktoren, ONR · Präradiotherapeutische Chirurgie · 
Chirurgiebedingte ORN · Postoperative ORN
Introduction
The risk for osteoradionecrosis ORN) of the mandible is 
known to be positively related to radiation doses of > 60 Gy 
to the bone [1, 2]. Patients at the highest risk for ORN are 
expectedly those who undergo definitive radiation therapy 
with doses of ~ 70–72 Gy for oral cavity cancer (OCC) or 
large central or lateralized mesopharyngeal cancer (MC) 
close to the mandible.
Grade 3 ORN was shown to be substantially reduced (to 
< 1 %) by the use of intensity-modulated radiation therapy 
(IMRT) techniques [3–8]; grade 1–2 ORN (healing after 
limited surgery such as debridement, decortication, seques-
trectomy, or spontaneously following conservative treat-
ment) was reported to be < 10 % in patients at risk [9].
In our OCC cohort, a higher ORN rate was observed in 
the postoperative subgroup (60–66 Gy in 2.0 Gy/fraction) 
than in the definitive IMRT subgroups as well as in the post-
operative IMRT MC cohort. This observation motivated us 
to analyze the impact of previous mandibular surgery on the 
risk for ORN.
Our hypothesis was that pre-IMRT surgery of the man-
dible may also be a risk factor for ORN.
Patients and methods
We retrospectively analyzed a single-center OCC/MC/
salivary gland tumor IMRT cohort with respect to ORN. 
Data were prospectively acquired in a StatView® database. 
Patients with ≥ 60 Gy to the mandible were included. The 
following potential risk cofactors were analyzed: surgical 
technique (no mandibular surgery vs. periosteal resection 
vs. segmental resection vs. marginal (horizontal or sagittal) 
resection), nicotine and alcohol abuse, carotid artery cal-
cification depicted in the planning computed tomography, 
comorbidities [diabetes, chronic obstructive pulmonary 
disease (COPD), peripheral arterial occlusive disease, coro-
nary heart disease, immunosuppression], age, gender, and 
T stage.
Approval from the local ethics committee was obtained 
for data evaluation of our IMRT cohort. The analysis start 
point was defined as the start of radiation.
Radiation dose
Postoperative IMRT prescription doses ranged between 60 
and 66 Gy in 2.0 Gy/fraction, definitive IMRT prescrip-
tion doses ranged between 68 and 72 Gy, mostly 70 Gy or 
69.6 Gy in 2.0 Gy or 2.11 Gy/fraction, five fractions per 
week. Attention was paid to avoid/minimize dose hot spots 
to the mandible. Early analyses of mandible dose–volumes 
of our first 73 IMRT patients at risk (included in the pres-
ent analysis) were previously reported [3]. Dose–volume 
histograms (DVHs) of the mandibles exposed to > 60.0 Gy 
were calculated. The maximum dose (Dmax) is defined as 
the highest dose in 1 %.
Details of the IMRT schedules used have been provided 
in previous reports [10, 11].
Systemic concomitant therapy
If indicated, cisplatin was concomitantly given (40 mg/
m2/week). Since April 2006, cetuximab has been used for 
patients with contraindications for cisplatin chemotherapy 
(400 mg/m2 loading dose, followed by 250 mg/m2 1 day/
week). Age and/or comorbidity or early-stage disease were 
reasons not to add systemic therapy (15 %).
Follow-up
All patients were regularly seen in our joint clinics 
3–6 weeks after completion of IMRT, at the Departments 
of Otorhinolaryngology and Head and Neck Surgery or the 
Department of Craniomaxillofacial and Oral Surgery. Our 
Head Neck Cancer Center standards for patient assessment 
include physical examination with additional flexible fiber-
optic endoscopy approximately every 2–3 months (MC) in 
the first follow-up (FU) year, every 3 months in the second 
to third year, and every 6 months in the fourth to fifth year.
ORN grading
 ● Out of several systems grading ORN, we used the sys-
tem proposed by Glanzmann and Graetz [1]:Grade 1: 
Exposed bone without signs of infection for at least 
3 months
 ● Grade 2: Exposed bone with signs of infection or seques-
ter, but not grades 3–5
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Of 715 patients, 531 (74 %) were exposed to > 60 Gy to 
the mandible, representing the population at risk (Table 2).
DVHs of the mandible
DVHs of the 531 patients at risk were calculated for all sub-
groups (Fig. 1). DVH mean values of postoperative IMRT 
MC patients were as expected significantly lower than those 
of postoperative IMRT OCC patients (p = 0.002). Postop-
erative IMRT OCC patients +/−ORN +/−mandible surgery 
(MS) and definitive IMRT MC patients without ORN had 
similar DVHs (ns). DVH values of definitive IMRT MC 
patients with ORN were nonsignificantly higher than those 
of patients with no ORN (unbalanced sample sizes: n = 16 
vs. 211). Definitive IMRT OCC patients were characterized 
by the highest mandibular DVH values. Mean Dmax point 
doses ranged between 67.8 and 68.7 Gy in postoperative 
 ● Grade 4: ORN with persistent problems despite man-
dibular resection
 ● Grade 5: Death due to ORN
In addition, “grade 2–3” ORN was introduced to grade ORN 
treatable with limited surgery, i.e., debridement, decortica-
tion, sequestrectomy.
ORN of the mandible that occurred in relation to invasive 
interventions (dental implants, tooth extractions, reconstruc-
tive/rehabilitative osseous or soft tissue surgery) on gingiva 
and/or mandible regions previously irradiated with doses 
> 50 Gy was termed "postintervention ORN." Exposed 
hardware after surgery was not considered as ORN, except 
for cases with secondary exposure after previous coverage.
Pre-IMRT surgical interventions on the mandible that 
were regarded as inclusion criteria for the term "mandibular 
surgery" (MS) were:
 ● Periosteal stripping
 ● Marginal resection
 ● Segmental resection
The time delay between surgery and radiation ranged 
between 4 weeks to 7.5 weeks (mean 5.5).
Dental care before/during/post radiation therapy
All patients underwent standardized dental care according 
to our in-house dental care protocol, which is characterized 
by its individual risk-adjusted approach [7].
Statistical analysis
Statistical calculations were carried out using the statistics 
program implemented in StatView® (version 4.5; SAS Insti-
tute, Cary, NC). Univariate analyses were performed with 
a Cox proportional hazards regression model in StatView®. 
Actuarial survival data were calculated using Kaplan–Meier 
curves and log-rank tests implemented in StatView®; p val-
ues of < 0.05 were considered statistically significant.
Multivariate analysis was performed using the StatView® 
calculation program (Mantel–Cox log-rank test). DVHs 




We assessed 715 locally disease-free OCC/OC/SGT IMRT 
patients who were treated at our department between Octo-
ber 2002 and October 2013. The mean FU was 38 months 
(7–143; Table 1).
Table 1 Study cohort
Parameters OCC MC SGT Total
Patients (N) 202 441 72 715
Gender (% males) 75 %
Mean age (range) 62 
(39–91)







197 428 21 646
Adenocarcinoma 0 3 19 22
Adenoid cystic 
carcinoma
1 0 15 16
Others 4 10 17 31
IMRT
Postoperative 145 97 69 311
Definitive 57 344 3 404
T stage
T1 28 73 11 112
T2 59 150 15 224
T3 23 97 25 145
T4 65 112 19 196
Recurrence 27 9 2 38
N stage
N0 72 75 29 176
N1-2b 86 232 38 270
N2c 31 107 4 142
N3 2 22 0 24
Recurrence 11 5 1 17
5-Year disease control (postoperative/definitive)
Local 75 %/40 % 96 %/77 % 95 %/50 %
Disease-free 
survival
62 %/36 % 80 %/61 % 73 %/0 %
Overall survival 71 %/27 % 86 %/73 % 88 %/75 %
FU follow-up, OCC oral cavity cancer, MC mesopharyngeal cancer, 
SGT salivary gland tumor.
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operative IMRT subgroups with lower IMRT doses (Fig. 1, 
dotted lines), with 17 ORN events in 282 patients (6 %) vs. 
19 of 249 operated patients ( 7.6%, ns; Table 2), suggesting 
an additional risk factor impacting the risk for ORN other 
than radiation dose only.
We observed 5 % (36/715) ORN events of grade 1–4 
in the entire cohort, and 7 % (36/531) in the cohort at risk 
(Table 2). All ORN events occurred in mandibles exposed 
to > 60 Gy.
Grade 1, 2, 2–3, 3, and 4 ORN events were observed in 2, 
5, 21, 4, and 4 patients, respectively.
Of 36 ORN events, eight (22 %) developed as a conse-
quence of invasive manipulation on previously with > 50 Gy 
irradiated bone areas (postintervention ORN): Four of eight 
events translated into complicated grade 4 ORN (pathologi-
cal fracture, osteocutaneous fistula, osteomyelitis, persisting 
pain) following segmental resection or limited surgery for 
ORN. Two patients were treated with segmental resection 
(grade 3) with uncomplicated FU. Four of the eight pos-
tintervention ORN patients underwent postoperative IMRT 
(marginal resection in two patients, segmental resection in 
two patients).
All grade 3 ORN occurred in the definitive IMRT MC 
cohort: in two of four patients after 70 Gy in 2.0 Gy/fraction 
(Dmax point doses 71.3 and 71.6 Gy, respectively), and in 
two of four following post-IMRT interventions.
The mean time from IMRT completion to ORN was 
20 months (range, 1–104); the corresponding time for pos-
tintervention ORN was also 20 months (2–50).
(ns) and between 72.4 and 73.6 Gy in definitive IMRT sub-
groups (ns).
Osteoradionecrosis
The definitive IMRT subgroups (characterized by higher 
IMRT doses to the mandible, Fig. 1, continuous lines) 
showed a tendency to have lower ORN rates than the post-
Table 2 Cohort at risk (531/715 patients with > 60 Gy to the mandible 







OCC, > 60 Gy to 
the mandible
1/52 (2 %) 18/106 (17 %) 19/158 (12 %)
ORN G1 0 0 0
ORN G2 0 0 0
ORN G2–3 0 15 15
ORN G3 0 0 0
ORN G4 1a 3a 4
MC, > 60 Gy to 
the mandible
16/227 (7 %) 0/74 (0 %) 16/301 (5 %)
ORN G1 2 0 2
ORN G2 4 0 4
ORN G2–3 6 0 6
ORN G3 4 0 4
SGT, > 60 Gy to 
the mandible
ORN G2 0/3 1/69 (1 %) 1/72 (1 %)
aFour of the eight postintervention osteoradionecrosis (ORN) cases 
observed in our cohort developed grade 4 ORN.
OCC oral cavity cancer, MC mesopharyngeal cancer, SGT salivary 
gland tumor.
Fig. 1  Mandible bone Dose–volume histograms (mean values, cc) of 
the following subgroups, all with the mandible exposed to > 60 Gy (n 
total = 458): -Postoperative IMRT in oral cavity cancer (OCC) patients 
with/without osteoradionecrosis (±ORN) who underwent mandibu-
lar surgery (+MS) or not (−MS) -Definitive IMRT in OCC patients 
(no MS, all in the cohort without ORN) -Definitive and postoperative 
IMRT in mesopharynx cancer (MC) patients ± ORN (none of them 
underwent mandibular surgery). Red curves represent the two cohorts 
with ORN (+ORN), dotted lines postoperative IMRT groups, and con-
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mobile tongue and severe pre-existing comorbidity (nico-
tine ± alcohol abuse, COPD, polyneuropathy, postoperative 
wound healing problems, low body mass index, etc.). The 
Dmax to the mandible was 66.7 Gy, 64.7 Gy, and 69.1 Gy, 
respectively.
Segmental resection was reasonably well tolerated (2 
ORN G2–3 in 27 patients, 7 %, Table 3), while marginal 
or periosteal resection translated into a significantly higher 
ORN rate (14/37, 38 %, p < 0.0001; 13 G2–3).
Surgical reconstruction in 65 patients at risk who under-
went mandibular surgery (Table 3) included insertion of a 
flap (48/65, 74 %), use of a free flap (40/48, 83 %), or tita-
nium osteosynthesis plates (30/65, 46 %). In the 16 of 65 
patients with ORN, a local or regional flap, a free vascular-
ized flap, and bridging osteosynthesis plates only were used 
in 12 of 16 (75 %), 12 of 12 (100 %), and 6 of 16 (38 %) 
patients, respectively; the corresponding numbers in the 
remaining 49 of 65 patients who developed no ORN were 
similar, with 34 of 49 (71 %), 28 of 34 (82 %), and 24 of 49 
(50 %), respectively (ns).
ORN in MC patients
The rate of grade 1–3 ORN in MC patients was 4 % (16/441): 
5 % (16/344) in the entire definitive IMRT MC cohort, 7 % 
(16/227) in patients with some aspect of the bone exposed 
to > 60 Gy (see Table 2). Dmax point doses to the mandible of 
the 16 ORN-affected patients were a mean 73.6 Gy (range, 
69.6–76.2 Gy). No ORN developed in 97 postoperative 
IMRT MC patients.
ORN in SGT patients
Of 69 postoperative patients treated with > 60 Gy to the 
ascending ramus or angle of the mandible, one patient was 
diagnosed with grade 2 ORN: In this patient IMRT follow-
ing periosteal resection and rarefication of the covering soft 
tissues resulted in a symptomatic necrosis of the condylar 
head (Table 2).
Other potential risk cofactors
Age and gender were equally distributed in the ORN and 
non-ORN patients. T stage in ORN patients was distributed 
ORN in definitive IMRT OCC patients
In this subgroup (Table 2) at highest risk (highest dose to 
largest mandible volume, Fig. 1), no ORN was diagnosed. 
Figure 2 shows Kaplan–Meier survival curves for ORN 
events following (1) definitive IMRT in MC patients and 
(2) postoperative IMRT in OCC patients: Most ORN events 
occurred early after IMRT completion, during the first 
20 months. Curve (3) shows the overall survival (OS) of 
definitive IMRT OCC patients with no ORN (except for 
one postintervention ORN): only 14 of 57 patients reached 
24 months.
ORN in postoperative IMRT OCC patients
Tumor sites in operated OCC were the following: lip 
(n = 2), maxilla (n = 10), top/central part of the mobile 
tongue (n = 10), cheek (n = 12), lateral border of the mobile 
tongue (n = 29), and floor of the mouth/mandible (n = 82; see 
Table 2).
The postoperative subgroup who underwent mandibu-
lar surgery showed a statistically significantly increased 
risk for ORN as compared with operated OCC patients 
with no mandibular surgery [15/60 (14 G2–3 + 1 G4 (pos-
tintervention ORN, 25 %) vs. 3/46 (7 %), p = 0.0009]; the 
three (G2–3) ORN patients without mandibular surgery 
were all diagnosed with a carcinoma of the border of the 
Fig. 2 Overall survival (OS) of definitively irradiated OCC patients, 
and ORN-free survival in the postoperative IMRT OCC and definitive 
IMRT MC cohorts. ORN osteoradionecrosis, OCC oral cavity cancer, 
MC mesopharyngeal cancer
 
Table 3 Types of mandibular surgery in postoperative IMRT patients at risk (> 60 Gy to the bone)
ORN in patients with mandibular surgery and > 60 Gy Total
OCC SGT MC
Type of mandibular surgery (15/60, 25 %) (1/3, 33 %) (0/2, 0 %) (16/65, 25 %)
Periosteal resection 5/13, 38 % 1/3, 33 % 0/1 6/17, 35 %
Marginal resection 8/20, 40 % 0 0 8/20, 40 %
Segmental resection 2/27, 7 % 0 0/1 2/28, 7 %
MC mesopharyngeal carcinoma, OCC oral cavity cancer, SGT salivary gland tumor.
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resection may take place with or without bone removal. This 
will lead to a denuded mandibular cortical plate with com-
promised healing capacity. In segmental resection cases the 
surgery is more extensive and mostly requires a composite 
free vascularized graft with a well-nourished bone flap with 
an unharmed periosteum and adequate soft tissue coverage.
Table 4 summarizes the ORN rates of our MC/OCC 
cohorts based on combined surgical and IMRT-related risk 
parameters. The fact that no ORN developed in 74 patients 
with postoperative MC vs. 17 % in 106 patients with postop-
erative OCC is explained by (a) the lower dose to the bone 
(DVH) and (b) only 2 of 74 cases underwent mandibular 
surgery in the MC subgroup. 
The observation of no ORN event (but one postinterven-
tion ORN) in the cohort at highest risk, i.e., definitively irra-
diated OCC, seems to be sufficiently explained by the fact of 
the survival time being too short to experience ORN (only 
~ 35 % surviving 20 months, Fig. 2). Poor outcome follow-
ing definitive irradiation of OCC also in the IMRT era was 
previously reported; however, data on this topic are scant 
[13], which may partly be explained by a negative selection 
of OCC patients referred for definitive radiation (elderly, 
comorbid patients with large/inoperable tumors). For the 
small subgroup (n = 14) who survived 2 years, we cannot 
exclude an ORN rate of approximately 22 % (according to 
the statistical "rule of three" to estimate the probability of 
adverse events in small sample sizes with few events, giving 
the upper limit of the 95 % confidence interval of the prob-
ability: 3/14 = 22 %).
as follows: recurrent tumors (3), T1 (5), T2 (1), T3 (6), and 
T4 (13). The tested risk cofactor rates were tendentially non-
significantly higher in the ORN than in the no-ORN cohort 
(nicotine 74 vs. 57 %, alcohol abuse 63 vs. 55 %, comorbid-
ity 43 vs. 34 %, carotid artery calcification in planning com-
puted tomography 31 vs. 26 %; unbalanced sample sizes: 36 
with ORN, 680 without ORN). Risk factor grouping (none 
vs. nicotine ± alcohol, vs. comorbidity + nicotine or alco-
hol) also resulted in nonsignificant differences in uni- and 
multivariate analyses.
Discussion
Previous surgery to the mandible, and mainly the type of 
surgery, was found to be the most important ORN risk 
parameter following IMRT.
In addition, this analysis confirmed that doses of 
< ~ 60–65 Gy to the mandible represent the lower thresh-
old for any risk of ORN. An ORN rate (grade 2–3) of 39 % 
was found for postoperative IMRT patients at risk with floor 
of the mouth carcinoma or mandible infiltrating carcinoma 
who underwent previous periosteal or marginal mandibular 
resection (Table 3). This was statistically significantly differ-
ent compared with postoperative IMRT OCC patients with 
no or segmental resection (7 %, each). A plausible explana-
tion for this finding is that the mandible is more dependent 
on the periosteum for its blood supply than on the inferior 
alveolar neurovascular bundle, especially in older individu-
als [12]. During surgery, significant periosteal stripping or 
Table 4 ORN rates related to mandibular surgery (MS) and DVH in OCC/MC patients at risk (> 60 Gy to the bone, n = 459; see also correspond-





MC postop with MS 
(2) (1 segmental, 1 
periosteal)
OCC postop with MS (60) OCC postop 
no MS (46)
MC def. no 
MS (227)
OCC def. no 




~ 11–5–2–0–0 cc 0 % 0 %




DVH dose–volume histogram, MC mesopharyngeal carcinoma, OCC oral CAVITY Cancer, postop postoperative IMRT (prescription dose 
60–66 Gy), def. definitive IMRT (prescription dose 70–72 Gy).
* see also Figure 2: short OAS of this subgroup
Table 5 Overview of the ORN events (crude rates) in the cohort at risk, related to surgery and IMRT sequence
Patients with mandible exposed to > 60 Gy (N = 531)
IMRT sequence Definitive IMRT (n = 282) Postoperative IMRT (n = 249))
Site SG OCC MC MC SG OCC
No mandibular 
surgery (n)
3/3 52/52 227/227 72/74 66/69 46/106
With mandibular 
surgery (n)
0 0 0 2/74 3/69 60/106
ORN 0 % (0/3) 2 % (1/52) 7 % (16/227) 0 % (0/74) 33 % (1/3) 0 % (0/66) 25 % (15/60) 7 % (3/46)
MC mesopharyngeal carcinoma, OCC oral cavity cancer, SG salivary gland tumor.
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4. Postoperative IMRT OCC patients with a dose of 
> 60 Gy to the mandible who underwent previous seg-
mental or no mandibular resection had significantly 
lower ORN rates (7 % each, p < 0.0001).
5. The ORN rate of definitive IMRT MC patients with 
> 60 Gy to the bone was 7 %.
6. Definitive IMRT OCC patients as the subgroup at theo-
retically highest risk for ORN were characterized by a 
very poor outcome with survival time in most patients 
shorter than the onset of ORN (negative selection of pa-
tients not suitable for surgery); this likely explains the 
low ORN rate in this subgroup.
7. Postoperative IMRT MC patients represented the sub-
group at lowest risk for ORN (0 %), explained by their 
lowest mandibular DVH values and only 2/97 cases 
with previous mandibular surgery.
8. Half the patients with postintervention ORN developed 
grade 4 ORN (4/8)
Conclusion
Periosteal or marginal mandibular resection was the statisti-
cally significantly highest ORN risk factor, translating into 
a 39 % ORN rate grade of 2–3, vs. 7 % following defini- 
tive IMRT or postoperative IMRT with no or segmental 
resection.
Consequently, the radiation dose to the mandible should 
be minimized in patients at high risk for ORN.
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